MT-701

· Mirador Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MT-701, covering 2026-02-09 to 2026-02-09. Get the full timeline:

Most recent: Clinical Trial Update: A First-in-Human Single and Multiple Ascending Dose Study of MT-701 [Phase 1]